Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.42 USD | +0.20% | -5.38% | -42.78% |
25/04 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
25/04 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.78% | 746M | |
+2.76% | 108B | |
+10.19% | 105B | |
+1.57% | 23.46B | |
-12.32% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-7.12% | 17.19B | |
+6.15% | 13.99B | |
+36.35% | 12.53B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Earnings Flash (SAGE) SAGE THERAPEUTICS Posts Q4 Revenue $78M, vs. Street Est of $61M